Erythrodermic Psoriasis
5 clinical trials · Condition
◉ Watch Erythrodermic Psoriasis
| Record | Firm | Date |
|---|---|---|
| Efficacy of Injection Sekucinumab in Erythrodermic Psoriasis (NCT06801028) | Jinnah Postgraduate Medical Centre | 2025-01-20 |
| A Study of TAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis (NCT06323356) | Takeda | 2024-03-19 |
| A Study of JNJ-77242113 for the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis (NCT06295692) | Janssen Pharmaceutical K.K. | 2024-02-09 |
| Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis) (NCT03885089) | Pfizer | 2019-10-21 |
| A Study of Ixekizumab (LY2439821) in Participants in Japan With Generalized Pustular Psoriasis and Erythrodermic Psoriasis (NCT03942042) | Eli Lilly and Company | 2019-07-05 |
Track Erythrodermic Psoriasis automatically
Every clearance here is in the API, with alerts when new ones post.